F&OMarket closed · Close · 13 Nov
Max Healthcare Institute Limited MAXHEALTH
₹947.10The price one share last traded at, in rupees.+0.08% · ₹0.76
52-wk low ₹79739% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹1,185
Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.
Loading prices…
Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.Test a strategy on MAXHEALTH
Real prices, every charge counted. Pick one or write your own.Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.
EOD 13 NovRSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
62.6Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
49.9%Near average
today 49.9%20d avg 57.8%
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.+1.1%vs 200 DMAHow far today's close is above or below the average closing price of the last 200 trading days, about ten months. It is the most watched line for the long-term trend.▼ 6.1%1 monthHow much the share price has changed over the period.+11.1%3 monthsHow much the share price has changed over the period.▼ 6.5%1 yearHow much the share price has changed over the period.▼ 16.6%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.26.3%
Are its options cheap or dear?It compares the movement option prices assume with the movement the share has actually shown.
Live in market hoursImplied volatility needs the live option chain, which is open 9:15 to 3:30.
Returns and valuationWhat the market pays for this company and how well the business uses its money.
Books to 30 Sept 2026Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹92,182 Cr13 NovP/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.66.7xlast 4 quarters, to Sept 2026Return on equityHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.14.3%full year FY26Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.8.13xbooks of Sept 2026Return on capitalHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.14.4%full year FY26EV / EBITDAWhat it would cost to buy the whole company, against the cash profit its business makes in a year. It is a P/E that ignores how the company is financed.40.5xDividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.21%last 12 monthsDebt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.33xbooks of Sept 2026FCF marginOf every ₹100 of sales, how much cash was left after running the business and paying for new assets.1.8%year to Mar 2026
Against its sectorWhere this company ranks among similar companies on each measure.
Hospital · 28 peers · mediansP/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.66.7vs 51.77 median
Cheapest: INDRAMEDCO 15.76Priciest: HCG 806.97
Net marginOf every ₹100 of sales, how much is left as profit after all costs, interest and tax.15.09%vs 10.01% median
Lowest: MAITREYA -7.51%Highest: KMCSHIL 17.52%
Revenue growthHow much sales grew in the latest quarter against the same quarter a year earlier.20.31%vs 23.64% median
Lowest: MAITREYA -0.09%Highest: SANGANI 673.79%
What the numbers sayShort plain statements about this company's latest figures.
Written by fixed rulesLatest quarterIn the quarter to September 2026 (results filed 30 Oct 2026), sales rose 20.3% from a year earlier to ₹2,569 cr and profit fell 15.6% to ₹414 cr.
Going well
- Sales grew 4 years running (₹3,932 cr in FY22 to ₹8,373 cr in FY26).
- Cash from operations was at least the reported profit in each of FY24, FY25, FY26.
Also changed
- Foreign institutions cut their holding by 14.2 points over 5 quarters (54.76% to 40.52%).
- Domestic institutions raised their holding by 13.6 points over 5 quarters (17.42% to 31.00%).
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
How the share moved on resultsWhat the share price did around each recent quarterly result.
Over the last 20 results, the share rose on 12 and fell on 8, and moved by 3% or more on 12.
+9%
-9%
Q2 FY23Q2 FY24Q2 FY25Q2 FY26Q2 FY27
Q2 FY27: results filed 30 Oct 2026. The share went from its close on 29 Oct 2026 to its close on 2 Nov 2026 +3.95%.
Dividends paidCash the company has paid per share, year by year.
₹210 / year
Paid 4 of 4 yrson ₹1 lakh at today's price · 0.21% yield · ₹2/share
What each year paid, on ₹1 lakh
106
158
158
211
23
24
25
26*
* 2026 so far - more may still be declared this year
2026 has paid ₹2.00 per share, about ₹211 on ₹1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.
What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.
Price only, before dividends+22.5%a year, over 5 years
1 yr
-13.7%
3 yr
+16.9%
5 yr
+22.5%
Held for 5 years this compounded at +22.5% a year. The last twelve months were down -13.7%. Price only, before dividends.
Who owns itThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.
Shareholding pattern23.71%promoter holding, as of 2026-09-30-37.2 pts since 2021
Promoter share since listing
2021-0923.71% now, drawn to its own range2026-09
Who owns it todayas of Sep 26
23.7%
40.5%
31.0%
Promoter23.7%Foreign (FII)40.5%Domestic (DII)31.0%Public & others4.8%
Who is buying, who is leavingJun 25 to Sep 26
Promoter23.7%steady
Foreign (FII)40.5%-14.2 pts
Domestic (DII)31.0%+13.6 pts
Each line is that holder's share of all shares over the last 6 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.
The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.
Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.
Last 6 monthsInvestor Presentation13-Nov-2026
Analysts/Institutional Investor Meet/Con. Call Updates09-Nov-2026
Analysts/Institutional Investor Meet/Con. Call Updates04-Nov-2026
Analysts/Institutional Investor Meet/Con. Call Updates03-Nov-2026
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company03-Nov-2026
Copy of Newspaper Publication31-Oct-2026
General Updates30-Oct-2026
Change in Management30-Oct-2026
Press Release30-Oct-2026
Outcome of Board Meeting30-Oct-2026
Allotment of Securities30-Oct-2026
ESOP/ESOS/ESPS30-Oct-2026
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company29-Oct-2026
Shareholders meeting27-Oct-2026
Analysts/Institutional Investor Meet/Con. Call Updates23-Oct-2026
At a glanceThe eight figures most people check first, each placed against companies in the same industry.
Against its sectorMarket capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹92,182 cr
Among the largest of 28 peers
sector middle ₹4,060 cr
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.
66.7x
Higher than 73% of 22 peers
sector middle 51.8x
Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.
8.1x
Higher than 88% of 26 peers
sector middle 5.3x
ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.
14.3%
Higher than 67% of 18 peers
sector middle 11.3%
FY23 14.9%FY26 14.3%
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.
14.4%
Lower than 57% of 23 peers
sector middle 14.8%
FY23 14.2%FY26 14.4%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.
0.33
Higher than 58% of 26 peers
sector middle 0.27
FY23 0.09FY26 0.32
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.2%
Higher than 79% of 28 peers
sector middle 0.0%
Sales growthHow much sales grew in the latest quarter against the same quarter a year earlier.
+20.3%
Lower than 64% of 22 peers
sector middle +23.6%
FY23 16.0%FY26 19.1%
Peers are the listed companies in the exchange's own industry group: Hospital. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
The business, year by yearSales and net profit by financial year or by quarter.
Sales and net profitFY22FY23FY24FY25FY26
SalesNet profitfell vs last yearEach on its own scale · hover a bar for its figures
Op. marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax.26.8%FY26Profit YoYHow much net profit grew in the latest quarter against the same quarter a year earlier.▼ 15.6%latest quarterSalesMoney earned from selling the company's goods and services, before any costs. Also called revenue.₹8,373 CrFY26Net profitWhat is left for shareholders after all costs, interest and tax.₹1,442 CrFY26
Where every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.
FY26In FY26, of every ₹100 of sales it kept ₹17.2 as profit. Other income added ₹1.9.
Where it wentPer ₹100 of sales
Running costs₹73.2Depreciation₹5.3Interest₹2.8Tax₹2.8Profit₹17.2Other items₹0.6Profit per ₹100, year by year
FY22FY26
How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.
Compounded a year3 years5 yearsLatest qtr
Sales+22.5%-+20.3%
Profit+9.3%-▼ 15.6%
Where the cash wentProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.
From the cash flow statementIn FY26 cash rose by ₹4 Cr, after ₹1,485 Cr spent on plant and equipment.
FY26Cash in or out
Running the business+₹1,633 Cr
Investing-₹1,689 Cr
Lenders and shareholders+₹59 Cr
Net change in cash+₹4 Cr
Operating cash per ₹100 of profit
₹110FY23₹106FY24₹136FY25₹113FY26
₹100 or more means the reported profit arrived as cash.Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.
| Measure | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales growthSales in this financial year against the previous one. | 16.0% | 18.6% | 30.0% | 19.1% |
| Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax. | 27.1% | 27.6% | 26.3% | 26.8% |
| Net marginOf every ₹100 of sales in the year, how much was left as profit after everything. | 24.2% | 19.6% | 15.3% | 17.2% |
| ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | 14.9% | 13.4% | 12.1% | 14.3% |
| ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders. | 14.2% | 16.0% | 14.2% | 14.4% |
| Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | 0.09x | 0.15x | 0.32x | 0.32x |
| Interest coverHow many times the company's profit before interest could pay its interest bill. | 13.7x | 23.8x | 9.5x | 8.1x |
Each row against this company's own usual level: green better, red worse, grey close to it.
Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.
Hospital| Company | What the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality. | How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit. | The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business. | How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | How much operating profit the company made on all the money in the business, whether it came from owners or lenders. | Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | Of every ₹100 of sales, how much is left as profit after all costs, interest and tax. | How much sales grew in the latest quarter against the same quarter a year earlier. | The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share. |
|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP Apollo Hospitals Enterprise Limited | 1.23 L cr | 54.7x | 11.6x | 21.5% | 20.7% | 0.50 | 8.4% | +20.8% | 0.23% |
| MAXHEALTH Max Healthcare Institute Limited | 92,182 cr | 66.7x | 8.1x | 14.3% | 14.4% | 0.33 | 15.1% | +20.3% | 0.21% |
| MANIPALHOS Manipal Health Enterprises Limited | 89,630 cr | - | 5.4x | - | - | 0.34 | - | - | 0.00% |
| ASTERDM Aster DM Quality Care Limited | 62,978 cr | 99.8x | 8.1x | 10.1% | 14.8% | 0.43 | 8.7% | +136.3% | 0.42% |
| FORTIS Fortis Healthcare Limited | 57,679 cr | 55.5x | 5.5x | 11.0% | 13.5% | 0.29 | 10.7% | +17.3% | 0.13% |
| MEDANTA Global Health Limited | 39,094 cr | 63.2x | 9.0x | 15.0% | 17.9% | 0.16 | 12.1% | +33.6% | 0.03% |
| NH Narayana Hrudayalaya Ltd. | 38,019 cr | 44.0x | 7.6x | 19.7% | 16.0% | 0.99 | 8.4% | +73.0% | 0.24% |
| KIMS Krishna Institute of Medical Sciences Limited | 30,646 cr | 139.8x | 7.8x | 9.7% | 9.9% | 0.83 | 4.3% | +39.9% | 0.00% |
| AGARWALEYE Dr. Agarwal's Health Care Limited | 17,462 cr | 102.0x | 7.8x | 8.3% | 15.2% | 0.09 | 8.7% | +31.4% | 0.00% |
| RAINBOW Rainbow Childrens Medicare Limited | 12,914 cr | 44.1x | 7.5x | 17.9% | 27.8% | 0.00 | 15.5% | +23.2% | 0.28% |
| PARKHOSPS Park Medi World Limited | 11,039 cr | 39.7x | 5.1x | 13.0% | 17.7% | 0.20 | 14.7% | - | 0.00% |
| YATHARTH Yatharth Hospital & Trauma Care Services Limited | 10,222 cr | 53.7x | 5.5x | 9.9% | 12.4% | 0.24 | 12.2% | +54.4% | 0.05% |
| JLHL Jupiter Life Line Hospitals Limited | 9,337 cr | 49.9x | 5.7x | 13.7% | 16.0% | 0.36 | 11.4% | +16.0% | 0.07% |
| HCG Healthcare Global Enterprises Limited | 8,554 cr | 807.0x | 6.3x | 1.9% | 9.4% | 0.52 | 0.8% | +13.1% | 0.00% |
| ARTEMISMED Artemis Medicare Services Limited | 5,094 cr | 44.4x | 5.2x | 11.6% | 14.8% | 0.24 | 10.0% | +13.2% | 0.14% |
| INDRAMEDCO Indraprastha Medical Corporation Limited | 3,027 cr | 15.8x | 3.7x | 27.5% | 37.7% | 0.00 | 12.3% | +8.3% | 1.21% |
| DRAGARWQ Dr Agarwals Eye Hospital Limited | 2,942 cr | 38.6x | - | - | - | - | 15.3% | +22.3% | 0.07% |
| KMCSHIL K M C Speciality Hospitals (India) Limited | 2,738 cr | 44.8x | - | - | - | - | 17.5% | +24.1% | 0.00% |
| SHALBY Shalby Limited | 1,340 cr | 35.0x | 1.3x | 3.5% | 6.7% | 0.53 | 3.2% | +9.7% | 0.00% |
| GKSL Gujarat Kidney And Super Speciality Limited | 1,228 cr | 57.0x | 4.7x | 6.6% | 8.6% | 0.06 | 16.2% | +194.6% | 0.00% |
| GPTHEALTH GPT Healthcare Limited | 1,180 cr | 22.6x | 4.1x | 16.3% | 23.1% | 0.05 | 10.2% | +14.1% | 1.39% |
| UNIHEALTH Unihealth Hospitals Limited | 851 cr | - | 8.2x | - | 16.2% | 0.13 | - | - | 0.00% |
| MOMSBELIEF Rays of Belief Limited | 592 cr | - | 3.9x | - | - | 0.15 | - | - | 0.00% |
| LOTUSEYE Lotus Eye Hospital and Institute Limited | 214 cr | 448.0x | 3.5x | 0.1% | 1.2% | 0.29 | 0.8% | +35.9% | 0.00% |
| NEPHROCARE Nephro Care India Limited | 154 cr | - | 2.5x | - | 8.7% | 0.00 | - | - | 0.00% |
| SANGANI Sangani Hospitals Limited | 83 cr | 27.6x | 2.0x | - | 19.6% | 0.04 | 7.6% | +673.8% | 0.00% |
| MAITREYA Maitreya Medicare Limited | 79 cr | - | 2.8x | - | -2.2% | 0.85 | -7.5% | -0.1% | 0.00% |
| AATMAJ Aatmaj Healthcare Limited | 60 cr | 105.6x | 1.2x | - | 3.6% | 0.45 | 1.9% | +56.9% | 0.00% |
| ABH ABH Healthcare Limited | 45 cr | - | 0.9x | - | - | 0.80 | - | - | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Month by monthThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.
Price return each month| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -8.4 | +14.1 | -11.9 | +3.2 | -2.8 | +17.0 | -2.7 | -5.1 | -10.8 | -7.5 | +10.1 | · | -9.4% 11m |
| 2025 | -5.9 | -7.8 | +12.2 | +0.1 | +2.5 | +13.4 | -2.4 | -7.4 | -3.4 | +3.0 | +1.3 | -10.1 | -7.4% |
| 2024 | +13.8 | +1.6 | +3.4 | +2.5 | -10.5 | +25.1 | -2.0 | -6.5 | +14.3 | +3.2 | -3.7 | +15.2 | +64.4% |
| 2023 | +0.5 | -3.5 | +3.5 | +4.3 | +19.4 | +9.1 | -0.8 | -0.9 | -3.8 | +1.1 | +10.8 | +7.9 | +56.1% |
| 2022 | -17.0 | +1.9 | -7.1 | +19.0 | -8.1 | -3.5 | +0.7 | +5.0 | +5.1 | +11.9 | -1.4 | -2.3 | -0.7% |
| 2021 | +15.7 | +11.8 | +13.5 | +10.3 | -2.0 | +14.4 | +16.5 | +30.0 | -6.7 | -7.8 | +14.7 | +16.5 | +216.0% |
| 2020 | · | · | · | · | · | · | · | · | +8.4 | -7.6 | +19.2 | +10.3 | +31.7% 4m |
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress
Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.
Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.
| Date | Party | Side | Quantity | Price | Value |
|---|---|---|---|---|---|
| 2026-03-18 | CITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITED · block | BUY | 7,94,904 | ₹976.00 | ₹77.58 Cr |
| 2026-03-18 | CITIGROUP GLOBAL MARKETS MAURITIUS PVT LTD · block | SELL | 7,94,904 | ₹976.00 | ₹77.58 Cr |
| 2025-09-29 | BNP PARIBAS FINANCIAL MARKETS · bulk | SELL | 82,90,713 | ₹1,111.66 | ₹921.65 Cr |
| 2025-09-29 | BNP PARIBAS FINANCIAL MARKETS · bulk | BUY | 3,53,042 | ₹1,125.02 | ₹39.72 Cr |
| 2025-07-14 | THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828 · block | SELL | 1,37,941 | ₹1,219.00 | ₹16.82 Cr |
| 2025-07-14 | THE MTBJ LTD. AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849 · block | BUY | 1,37,941 | ₹1,219.00 | ₹16.82 Cr |
| 2025-05-14 | MORGAN STANLEY ASIA SINGAPORE PTE · block | SELL | 2,58,242 | ₹1,172.00 | ₹30.27 Cr |
| 2025-05-14 | CITIGROUP GLOBAL MARKETS MAURITIUS PVT LTD · block | BUY | 2,58,242 | ₹1,172.00 | ₹30.27 Cr |
- Board outcomeOutcome of Board Meeting30 Oct 2026
Max Healthcare Institute Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
- Board outcomeOutcome of Board Meeting13 Aug 2026
Max Healthcare Institute Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
- Board outcomeOutcome of Board Meeting21 May 2026
Max Healthcare Institute Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
- Board outcomeOutcome of Board Meeting5 Feb 2026
Max Healthcare Institute Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
- Board outcomeOutcome of Board Meeting14 Nov 2025
Max Healthcare Institute Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
- Board outcomeOutcome of Board Meeting13 Aug 2025
Max Healthcare Institute Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
- Board outcomeOutcome of Board Meeting20 May 2025
Max Healthcare Institute Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
- Integrated Filing- Financial30 Jan 2025
Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024
- Financial Result Updates30 Jan 2025
Max Healthcare Institute Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.
Read enough? Test MAXHEALTH. “Buy MAXHEALTH when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.
Run it free